How much does Conmana (Icotinib Hydrochloride Tablets) Cost& price without insurance in China?
Conmana® is the commercial brand name of Icotinib Hydrochloride Tablets, an orally administered epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) independently developed in China. It selectively inhibits EGFR tyrosine kinase activity, blocks downstream signal transduction, and suppresses proliferation and metastasis of tumor cells carrying EGFR mutations.
Main Indications
First-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) confirmed to have sensitive EGFR gene mutations.
Second-line treatment of locally advanced or metastatic NSCLC previously failed at least one chemotherapy regimen.
Common Side Effects
Common mild adverse reactions: Rash, diarrhea, dry skin, pruritus, fatigue, nausea and elevated transaminases.
Laboratory abnormalities: Increased liver enzyme levels, decreased leukocyte count.
Severe but uncommon risks: Interstitial lung disease, severe cutaneous adverse reactions, severe liver function damage.
Approval Status in China
Conmana® (Icotinib Hydrochloride Tablets, 125mg) was officially approved for marketing in China in 2011. It is a prescription targeted anti-tumor drug included in China’s Category B medical insurance list.
Buy Conmana (Icotinib Hydrochloride Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
